Jyong Biotech Ltd. (MENS)

Jyong Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-3.98	-4.4	-6.63	-4.2	-1.92
Depreciation & Amortization	0.12	0.13	0.12	0.12	0.11
Other Adjustments	0.65	0.55	0.6	0.85	0.8
Changes in Accounts Payable	0	-0	-0.03	0.01	-0.1
Changes in Accrued Expenses	-0.86	1.12	2.8	1.1	0.07
Changes in Other Operating Activities	-0.01	-0	0.17	0.14	-0.05
Operating Cash Flow	-4.08	-2.6	-2.97	-1.98	-1.09
Capital Expenditures	-	-	-0.25	-0.14	-0.09
Purchases of Intangible Assets	-	-	-	-	-0
Purchases of Investments	-	-	-0.29	-1.83	-0.66
Proceeds from Sale of Investments	-	0.1	1.93	0.66	1.48
Investing Cash Flow	-	0.1	1.39	-1.31	0.73
Short-Term Debt Issued	11.88	11.83	12.28	5.62	7.2
Short-Term Debt Repaid	-8.85	-9.23	-8.38	-6.81	-2.92
Net Short-Term Debt Issued (Repaid)	3.03	2.6	3.9	-1.19	4.28
Long-Term Debt Issued	-	-	-	0.02	0.73
Long-Term Debt Repaid	-0.09	-0.12	-0.29	-0.21	-0.1
Net Long-Term Debt Issued (Repaid)	-0.09	-0.12	-0.29	-0.19	0.63
Other Financing Activities	-0.36	-0.45	-0.28	-	-
Financing Cash Flow	2.46	2.03	3.33	-1.38	4.91
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.01	-0.05	-0.03	0.07	0.14
Net Cash Flow	-1.62	-0.53	1.72	-4.61	4.7
Beginning Cash & Cash Equivalents	1.72	4.55	1.1	5.16	0.46
Ending Cash & Cash Equivalents	0.1	1.74	2.27	0.55	5.16
Free Cash Flow	-4.08	-2.6	-3.22	-2.12	-1.18
Free Cash Flow Per Share	-0.06	-0.04	-0.04	-0.03	-0.02
Levered Free Cash Flow	-1.79	-0.68	-0.21	-4.35	2.93
Unlevered Free Cash Flow	-3.38	-1.55	-0.02	-1.18	-2.51

Updated Jun 30, 2024. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q